Suicide risk during pregnancy and the postpartum, use of modafinil in pregnancy, and new treatment for menopausal symptoms are featured in this week’s roundup.
Read the Latest News
Drawing on current research and clinical expertise, these articles address emerging trends, treatment considerations, and the complexities of care across the reproductive lifespan.
If you or someone you know is in crisis, confidential support is available.
A new study examines pregnancy outcomes among women using stimulants or atomoxetine during pregnancy, finding modest increases in some complications with stimulant use while highlighting important limitations of observational data.
A large claims-based study found no increased risk for most outcomes with first-trimester stimulant exposure during pregnancy, but higher risks when use continued later in pregnancy.
Sign up for our newsletter
Get the latest news in women’s mental health and our research.
"*" indicates required fields
